Healthcare provider profile · identity verified

Rebecca D Pfaff, MD

Family Practice · OMAK, WA · NPI 1669730644

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	137	33
Lisinopril	Lisinopril	125	27
Metoprolol Succinate	Metoprolol Succinate	116	24
Omeprazole	Omeprazole	100	21
Losartan Potassium	Losartan Potassium	96	28
Hydrochlorothiazide	Hydrochlorothiazide	92	26
Gabapentin	Gabapentin	76	18
Furosemide	Furosemide	74	18
Levothyroxine Sodium	Levothyroxine Sodium	70	15
Metformin Hcl Er	Metformin Hcl	57	suppressed
Amlodipine Besylate	Amlodipine Besylate	50	11
Xarelto	Rivaroxaban	49	suppressed
Potassium Chloride	Potassium Chloride	43	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	13
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Metformin Hcl	Metformin Hcl	34	suppressed
Sertraline Hcl	Sertraline Hcl	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Famotidine	Famotidine	31	suppressed
Simvastatin	Simvastatin	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Eliquis	Apixaban	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Trazodone Hcl	Trazodone Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Lactulose	Lactulose	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Topiramate	Topiramate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Atenolol	Atenolol	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Clonidine	Clonidine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Prednisone	Prednisone	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Estradiol	Estradiol	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Naproxen	Naproxen	11	suppressed
Risperidone	Risperidone	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error